ISARIC's purpose is to prevent illness and deaths from infectious disease outbreaks. We are a global federation of clinical research networks, providing a proficient, coordinated, and agile research response to outbreak-prone infectious diseases.
The results in this report have been produced using data from the ISARIC COVID-19 database. We welcome additional partners to collaborate in this effort. Please contact ncov@isaric.org.
Click here to download the latest report.
Thank you to our frontline colleagues who selflessly continue to contribute data to better understand COVID-19, to improve patient care, and to inform policy & planning.
Today a report was released that calls for the use of research evidence on the optimal implementation of public health interventions for COVID-19 in varied global settings. In the ...
Major infectious disease outbreaks are a constant threat to human health. Clinical research responses to outbreaks generate evidence to improve outcomes and outbreak control. Experiences from previous epidemics have identified ...
Background: Reports of ethnic inequalities in COVID-19 outcomes are conflicting and the reasons for any differences in outcomes are unclear. We investigated ethnic inequalities in critical care admission patterns, the ...
“To make clinical and biological observations in a time-frame likely to benefit patients during disease outbreaks, coordination in global research must match the speed of spread of novel pathogens. ...
The PHOSP-COVID study has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). This study is one of a number of COVID-19 studies that have been given urgent public health research ... Read more
At the beginning of the pandemic, the possibility that warmer weather could reduce the transmission of COVID-19 in the northern hemisphere was repeatedly raised by the public, media and the scientific community. [1-3] As weeks and months continue to pass, ... Read more
Professor Peter Horby and Professor Martin Landray, chief investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial, said: In March this year, RECOVERY was established as a randomised clinical trial to test a range of potential treatments for COVID-19, ... Read more